Anteris Technologies Global (NASDAQ:AVR) Trading Down 4.5% – Should You Sell?

Anteris Technologies Global Corp. (NASDAQ:AVRGet Free Report) dropped 4.5% during trading on Friday . The stock traded as low as $5.82 and last traded at $5.97. Approximately 1,259,083 shares were traded during mid-day trading, a decline of 31% from the average daily volume of 1,817,860 shares. The stock had previously closed at $6.25.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AVR. Weiss Ratings restated a “sell (e+)” rating on shares of Anteris Technologies Global in a research note on Monday, December 29th. Lake Street Capital reissued a “buy” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a report on Friday, January 23rd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $15.00.

View Our Latest Research Report on AVR

Anteris Technologies Global Stock Down 4.5%

The company’s 50-day moving average price is $5.05 and its 200 day moving average price is $4.48. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.80 and a current ratio of 0.84. The stock has a market cap of $245.96 million and a PE ratio of -3.30.

Anteris Technologies Global (NASDAQ:AVRGet Free Report) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.05). Anteris Technologies Global had a negative return on equity of 252.71% and a negative net margin of 3,944.93%.The business had revenue of $0.43 million during the quarter, compared to analysts’ expectations of $0.74 million. As a group, analysts forecast that Anteris Technologies Global Corp. will post -2.66 EPS for the current fiscal year.

Hedge Funds Weigh In On Anteris Technologies Global

Institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Anteris Technologies Global during the first quarter valued at $32,000. Geode Capital Management LLC raised its stake in shares of Anteris Technologies Global by 154.3% in the second quarter. Geode Capital Management LLC now owns 420,427 shares of the company’s stock worth $1,593,000 after buying an additional 255,088 shares during the period. Intech Investment Management LLC purchased a new position in shares of Anteris Technologies Global during the 2nd quarter valued at about $49,000. JPMorgan Chase & Co. lifted its position in shares of Anteris Technologies Global by 9,958.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock valued at $4,049,000 after buying an additional 1,057,707 shares in the last quarter. Finally, Affinity Asset Advisors LLC grew its stake in shares of Anteris Technologies Global by 9.0% during the 2nd quarter. Affinity Asset Advisors LLC now owns 425,000 shares of the company’s stock valued at $1,611,000 after acquiring an additional 35,000 shares during the period.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Read More

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.